JACOBS LEVY EQUITY MANAGEMENT, INC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 190 filers reported holding HERON THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$4,583,000
-56.0%
295,276
-54.0%
0.03%
-61.2%
Q1 2021$10,415,000
+1811.0%
642,475
+2394.3%
0.08%
+1500.0%
Q4 2020$545,000
+55.3%
25,758
-14.0%
0.01%0.0%
Q1 2020$351,000
+83.8%
29,938
+183.5%
0.01%
+25.0%
Q2 2016$191,000
-74.0%
10,560
-72.7%
0.00%
-75.0%
Q1 2016$734,00038,6600.02%
Other shareholders
HERON THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders